226 related articles for article (PubMed ID: 9484791)
1. Indolocarbazoles: potent and selective inhibitors of platelet-derived growth factor receptor autophosphorylation.
Spacey GD; Uings IJ; Slater M; Hirst S; Bonser RW
Biochem Pharmacol; 1998 Feb; 55(3):261-71. PubMed ID: 9484791
[TBL] [Abstract][Full Text] [Related]
2. A dual inhibitor of platelet-derived growth factor beta-receptor and Src kinase activity potently interferes with motogenic and mitogenic responses to PDGF in vascular smooth muscle cells. A novel candidate for prevention of vascular remodeling.
Waltenberger J; Uecker A; Kroll J; Frank H; Mayr U; Bjorge JD; Fujita D; Gazit A; Hombach V; Levitzki A; Böhmer FD
Circ Res; 1999 Jul; 85(1):12-22. PubMed ID: 10400906
[TBL] [Abstract][Full Text] [Related]
3. Effects of the indolocarbazole 3744W on the tyrosine kinase activity of the cytoplasmic domain of the platelet-derived growth factor beta-receptor.
Uings IJ; Spacey GD; Bonser RW
Cell Signal; 1999 Feb; 11(2):95-100. PubMed ID: 10048786
[TBL] [Abstract][Full Text] [Related]
4. Selective inhibition of platelet-derived growth factor (PDGF) receptor autophosphorylation and PDGF-mediated cellular events by a quinoline derivative.
Yagi M; Kato S; Kobayashi Y; Kubo K; Oyama S; Shimizu T; Nishitoba T; Isoe T; Nakamura K; Ohashi H; Kobayashi N; Iinuma N; Osawa T; Onose R; Osada H
Exp Cell Res; 1997 Aug; 234(2):285-92. PubMed ID: 9260896
[TBL] [Abstract][Full Text] [Related]
5. Sodium butyrate inhibits platelet-derived growth factor-induced proliferation of vascular smooth muscle cells.
Ranganna K; Joshi T; Yatsu FM
Arterioscler Thromb Vasc Biol; 1995 Dec; 15(12):2273-83. PubMed ID: 7489253
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory mechanism of tranilast in human coronary artery smooth muscle cells proliferation, due to blockade of PDGF-BB-receptors.
Watanabe S; Matsuda A; Suzuki Y; Kondo K; Ikeda Y; Hashimoto H; Umemura K
Br J Pharmacol; 2000 May; 130(2):307-14. PubMed ID: 10807667
[TBL] [Abstract][Full Text] [Related]
7. Differences in signal transduction between platelet-derived growth factor (PDGF) alpha and beta receptors in vascular smooth muscle cells. PDGF-BB is a potent mitogen, but PDGF-AA promotes only protein synthesis without activation of DNA synthesis.
Inui H; Kitami Y; Tani M; Kondo T; Inagami T
J Biol Chem; 1994 Dec; 269(48):30546-52. PubMed ID: 7982973
[TBL] [Abstract][Full Text] [Related]
8. Platelet-derived growth factor-BB and thrombin activate phosphoinositide 3-kinase and protein kinase B: role in mediating airway smooth muscle proliferation.
Walker TR; Moore SM; Lawson MF; Panettieri RA; Chilvers ER
Mol Pharmacol; 1998 Dec; 54(6):1007-15. PubMed ID: 9855629
[TBL] [Abstract][Full Text] [Related]
9. Platelet-derived growth factor-BB-induced human smooth muscle cell proliferation depends on basic FGF release and FGFR-1 activation.
Millette E; Rauch BH; Defawe O; Kenagy RD; Daum G; Clowes AW
Circ Res; 2005 Feb; 96(2):172-9. PubMed ID: 15625285
[TBL] [Abstract][Full Text] [Related]
10. Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell.
Arita Y; Kihara S; Ouchi N; Maeda K; Kuriyama H; Okamoto Y; Kumada M; Hotta K; Nishida M; Takahashi M; Nakamura T; Shimomura I; Muraguchi M; Ohmoto Y; Funahashi T; Matsuzawa Y
Circulation; 2002 Jun; 105(24):2893-8. PubMed ID: 12070119
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine kinase activity of purified recombinant cytoplasmic domain of platelet-derived growth factor beta-receptor (beta-PDGFR) and discovery of a novel inhibitor of receptor tyrosine kinases.
Zaman GJ; Vink PM; van den Doelen AA; Veeneman GH; Theunissen HJ
Biochem Pharmacol; 1999 Jan; 57(1):57-64. PubMed ID: 9920285
[TBL] [Abstract][Full Text] [Related]
12. In vitro pharmacological characterization of PD 166285, a new nanomolar potent and broadly active protein tyrosine kinase inhibitor.
Panek RL; Lu GH; Klutchko SR; Batley BL; Dahring TK; Hamby JM; Hallak H; Doherty AM; Keiser JA
J Pharmacol Exp Ther; 1997 Dec; 283(3):1433-44. PubMed ID: 9400019
[TBL] [Abstract][Full Text] [Related]
13. Platelet-derived growth factor-BB (PDGF-BB) regulation of migration and focal adhesion kinase phosphorylation in rabbit aortic vascular smooth muscle cells: roles of phosphatidylinositol 3-kinase and mitogen-activated protein kinases.
Cospedal R; Abedi H; Zachary I
Cardiovasc Res; 1999 Mar; 41(3):708-21. PubMed ID: 10435043
[TBL] [Abstract][Full Text] [Related]
14. Cudratricusxanthone A isolated from the root bark of Cudrania tricuspidata inhibits the proliferation of vascular smooth muscle cells through the suppression of PDGF-receptor beta tyrosine kinase.
Kim TJ; Han HJ; Hong SS; Hwang JH; Hwang BY; Yoo HS; Jin YR; Lee JJ; Yu JY; Lee KH; Kang BW; Yun YP
Biol Pharm Bull; 2007 Apr; 30(4):805-9. PubMed ID: 17409526
[TBL] [Abstract][Full Text] [Related]
15. v-mos suppresses platelet-derived growth factor (PDGF) type-beta receptor autophosphorylation and inhibits PDGF-BB-mediated signal transduction.
Faller DV; Mundschau LJ; Forman LW; Quiñones MA
J Biol Chem; 1994 Feb; 269(7):5022-9. PubMed ID: 8106477
[TBL] [Abstract][Full Text] [Related]
16. Platelet-derived growth factor beta-receptors can both promote and inhibit chemotaxis in human vascular smooth muscle cells.
Clunn GF; Refson JS; Lymn JS; Hughes AD
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2622-9. PubMed ID: 9409235
[TBL] [Abstract][Full Text] [Related]
17. Endothelin-1 potentiates human smooth muscle cell growth to PDGF: effects of ETA and ETB receptor blockade.
Yang Z; Krasnici N; Lüscher TF
Circulation; 1999 Jul; 100(1):5-8. PubMed ID: 10393673
[TBL] [Abstract][Full Text] [Related]
18. Antiproliferative activity of NQ304, a synthetic 1,4-naphthoquinone, is mediated via the suppressions of the PI3K/Akt and ERK1/2 signaling pathways in PDGF-BB-stimulated vascular smooth muscle cells.
Kim TJ; Yun YP
Vascul Pharmacol; 2007 Jan; 46(1):43-51. PubMed ID: 16875883
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cell growth: effects of the tyrosine kinase inhibitor CGP 53716.
Major TC; Keiser JA
J Pharmacol Exp Ther; 1997 Oct; 283(1):402-10. PubMed ID: 9336349
[TBL] [Abstract][Full Text] [Related]
20. The fumagillin analogue TNP-470 inhibits DNA synthesis of vascular smooth muscle cells stimulated by platelet-derived growth factor and insulin-like growth factor-I. Possible involvement of cyclin-dependent kinase 2.
Koyama H; Nishizawa Y; Hosoi M; Fukumoto S; Kogawa K; Shioi A; Morii H
Circ Res; 1996 Oct; 79(4):757-64. PubMed ID: 8831499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
